Novavax | NVAX - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Adma Biologics USD 4.34B 845M 2025-12
Agenus USD 107M 16M 2025-12
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Cassava Sciences USD 96M 45M 2025-12
Geron USD 946M 9M 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
MannKind USD 965M 208M 2026-05
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Novavax USD 1.09B 316M 2025-12
Pfizer USD 147.4B 6.42B 2026-05
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
TG Therapeutics USD 6.48B 1.18B 2026-05